Indianapolis, IN, United States of America

John J Turchi

This inventor holds 10 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents. Top assignees: Indiana University, Indiana State University. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John J Turchi. Retrieved from https://idiyas.com/inventor/john-j-turchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 80.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

Indiana State University

patents

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12703695 - Ku inhibitors and their use (2026-08-11),

2. 12486246 - Replication protein A (RPA)-DNA interaction inhibitors (2025-12-02),

3. 11207296 - XPA inhibitor compounds and their use (2021-12-28),

4. 11098033 - Ku inhibitors and their use (2021-08-24),

5. 10774063 - Materials and method for inhibiting replication protein A and uses thereof (2020-09-15),

6. 9757350 - Small molecule inhibitors of replication protein A that also act synergistically with cisplatin (2017-09-12),

7. 9730942 - Materials and method for inhibiting replication protein A and uses thereof (2017-08-15),

8. 9533969 - Materials and method for inhibiting replication protein A and uses thereof (2017-01-03),

9. 8980955 - Small molecule inhibitors of replication protein A that also act synergistically with cisplatin (2015-03-17),

10. 8859532 - Materials and method for inhibiting replication protein A and uses thereof (2014-10-14),

Title: John J Turchi: Innovator in Cancer Treatment and Genome Engineering

Introduction

John J Turchi is a prominent inventor based in Indianapolis, IN (US), known for his significant contributions to the fields of cancer treatment and genome engineering. With a total of 10 patents, Turchi has made remarkable strides in developing innovative compounds that target specific biological pathways.

Latest Patents

Among his latest patents are the XPA inhibitor compounds and their use, which focus on certain compounds that exhibit binding affinity for XPA. This disclosure highlights the potential of XPA inhibitors in methods of treating cancer. Another notable patent is related to Ku inhibitors and their use, which discusses compounds that bind to Ku and their applications in site-specific genome engineering technologies. This includes advanced techniques such as CRISPR/Cas9, Zinc finger nuclease (ZFN), Transcription activator-like effector nuclease (TALEN), and meganuclease. Additionally, the patent outlines kits that are useful for site-specific genome engineering, incorporating at least one of the described compounds.

Career Highlights

Throughout his career, John J Turchi has been associated with esteemed institutions such as Indiana University and Indiana State University. His work has not only advanced scientific knowledge but has also paved the way for practical applications in medicine and biotechnology.

Collaborations

Turchi has collaborated with notable colleagues, including Sarah Shuck and Richard W Fitch, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

John J Turchi's contributions to the fields of cancer treatment and genome engineering exemplify the impact of innovative thinking in science. His patents and collaborations continue to influence research and development in these critical areas.

Profile summary based on public USPTO records.